Similar articles for PMID: 25926129

Year	Number of Results
1964	1
1969	2
1973	1
1978	1
1980	1
1982	2
1983	2
1984	2
1986	1
1987	1
1989	2
1990	1
1991	3
1992	1
1994	1
2001	1
2002	1
2003	1
2005	1
2006	1
2007	2
2008	2
2009	3
2010	8
2011	5
2012	11
2013	7
2014	16
2015	17
2016	12
2017	17
2018	21
2019	14
2020	17
2021	14
2022	9
2023	5
2024	0

1

Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?

Casteleijn NF, Zittema D, Bakker SJ, Boertien WE, Gaillard CA, Meijer E, Spithoven EM, Struck J, Gansevoort RT. Casteleijn NF, et al. Am J Nephrol. 2015;41(3):248-56. doi: 10.1159/000382081. Epub 2015 Apr 25. Am J Nephrol. 2015. PMID: 25926129 Free article.

2

Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.

Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT. Zittema D, et al. Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19. Clin J Am Soc Nephrol. 2012. PMID: 22516290

3

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.

Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Boertien WE, et al. Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953

4

Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.

Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT. Boertien WE, et al. Nephrol Dial Transplant. 2012 Nov;27(11):4131-7. doi: 10.1093/ndt/gfs070. Epub 2012 Apr 20. Nephrol Dial Transplant. 2012. PMID: 22523115

5

Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.

Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Boertien WE, et al. Am J Kidney Dis. 2013 Mar;61(3):420-9. doi: 10.1053/j.ajkd.2012.08.038. Epub 2012 Oct 22. Am J Kidney Dis. 2013. PMID: 23089511 Free PMC article.

6

Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).

Nakajima A, Lu Y, Kawano H, Horie S, Muto S. Nakajima A, et al. Clin Exp Nephrol. 2015 Dec;19(6):1199-205. doi: 10.1007/s10157-015-1101-7. Epub 2015 Feb 27. Clin Exp Nephrol. 2015. PMID: 25715868

7

Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.

Meijer E, Bakker SJ, van der Jagt EJ, Navis G, de Jong PE, Struck J, Gansevoort RT. Meijer E, et al. Clin J Am Soc Nephrol. 2011 Feb;6(2):361-8. doi: 10.2215/CJN.04560510. Epub 2010 Oct 7. Clin J Am Soc Nephrol. 2011. PMID: 20930090 Free PMC article.

8

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.

Zittema D, Casteleijn NF, Bakker SJ, Boesten LS, Duit AA, Franssen CF, Gaillard CA, Gansevoort RT. Zittema D, et al. PLoS One. 2017 Jan 12;12(1):e0169263. doi: 10.1371/journal.pone.0169263. eCollection 2017. PLoS One. 2017. PMID: 28081165 Free PMC article. Clinical Trial.

9

Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.

Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT. Zittema D, et al. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1553-62. doi: 10.2215/CJN.08690813. Epub 2014 Jul 3. Clin J Am Soc Nephrol. 2014. PMID: 24993447 Free PMC article.

10

Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial.

Amro OW, Paulus JK, Noubary F, Perrone RD. Amro OW, et al. Am J Kidney Dis. 2016 Dec;68(6):882-891. doi: 10.1053/j.ajkd.2016.07.023. Epub 2016 Sep 20. Am J Kidney Dis. 2016. PMID: 27663039 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year